AstraZeneca and Roche Diagnostics Asia Pacific have signed a three-year Memorandum of Understanding to support the development of digital and computational pathology capabilities across nine Asian markets.

• The collaboration will introduce training and educational initiatives to support clinical workflows and the integration of AI-assisted pathology systems.
• The programme spans Singapore, Taiwan, South Korea, Thailand, Malaysia, India, Indonesia, Vietnam, and the Philippines.
• It aims to improve interpretation concordance by up to 15%, increase diagnostic accuracy by up to 5%, and reduce reading time per case by 36%, based on referenced studies cited in the release.

This summary is based on a press release issued by AstraZeneca and distributed via PR Newswire.

Image for illustrative purposes only. Source: Canva.

About Ehub365

For Corporate Clients, ehub365 division delivers critical insights into the ASEAN medical sector, covering investments, new services, and practitioner news. 

A member of 365Asia. Our additional group services are Health365, 365Asia, 健康365, 365Sehat, and 365MEC.